Wave Life Sciences Announces Nucleic Acids Research Publication Highlighting Potential Best-in-Class siRNAs Designed with Wave Platform Chemistry
Published preclinical data demonstrate unprecedented Ago2 loading following administration of single subcutaneous siRNA dose, leading to improved potency and durability in vivo versus comparator siRNA... | April 20, 2023
United Kingdom Paul Bolno Chandra Vargeese Kate Rausch Wave Life Sciences Nasdaq Wave Life Sciences Fourth Quarter
Source: marketscreener.com